publication date: Dec. 22, 2010
In this issue:
BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal;
SEC Notifies ImClone It May Bring Action Against Company;
Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study;
NCAB Grants Three MERIT Awards; Rimer To Leave NCI For Post At UNC;
NRSAs Renamed For Kirschstein.
Download (PDF 194KB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.